Results 121 to 130 of about 24,129,507 (192)

Severe and complicated Malaria due to P. vivax [PDF]

open access: yesInternational Journal of Infectious Diseases, 2010
openaire   +1 more source

Molecular Evidence of Plasmodium Vivax Infection in Duffy-Negative Symptomatic Autochthones Individuals from West Cameroon

open access: yes, 2017
Background: Plasmodium vivax (P. vivax) is considered as absent in West/Central Africa because of the high prevalence of Duffy antigen negativity in the local human population. Duffy antigen on red blood cells is the only well-known receptor allowing the
Mpoame, Mbida   +7 more
core  

TLR9 gene polymorphism -1237T/C (rs5743836) is associated with low IgG antibody response against PvCSP variants in symptomatic P. vivax infections in Venezuela. [PDF]

open access: yesPLoS Negl Trop Dis
Carrión-Nessi FS   +5 more
europepmc   +1 more source

Longitudinal ex vivo and molecular trends of chloroquine and piperaquine activity against Plasmodium falciparum and P. vivax before and after introduction of artemisinin-based combination therapy in Papua, Indonesia. [PDF]

open access: yesInt J Parasitol Drugs Drug Resist, 2021
Marfurt J   +21 more
europepmc   +1 more source

Treatment, Prophylaxis and Resistance in P. vivax Malaria [PDF]

open access: yesInternational Journal of Infectious Diseases, 2010
openaire   +1 more source

Loop-mediated isothermal amplification (LAMP) assays targeting 18S ribosomal RNA genes for identifying P. vivax and P. ovale species and mitochondrial DNA for detecting the genus Plasmodium. [PDF]

open access: yesParasit Vectors, 2021
Chen X   +18 more
europepmc   +1 more source

P. falciparum and P. vivax Orthologous Coiled-Coil Candidates for a Potential Cross-Protective Vaccine. [PDF]

open access: yesFront Immunol, 2020
Ayadi I   +12 more
europepmc   +1 more source

Diagnostic Practices and Treatment for P. vivax in the InterEthnic Therapeutic Encounter of South-Central Vietnam: A Mixed-Methods Study. [PDF]

open access: yesPathogens, 2020
Nguyen TT   +12 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy